Journal
CELLS
Volume 10, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/cells10113158
Keywords
rare diseases; monogenic diseases; mouse models; CRISPR/Cas9 ; genome engineering; Finnish disease heritage
Categories
Funding
- Jane and Aatos Erkko Foundation, FinnDisMice consortium
- Helsinki Institute of Life Science (HiLIFE), University of Helsinki
- Foundation for Pediatric Research
- Academy of Finland [331436]
- University of Oulu [311934]
- University of Helsinki
- Academy of Finland (AKA) [331436] Funding Source: Academy of Finland (AKA)
Ask authors/readers for more resources
The modification of genes in animal models has significantly improved our understanding of rare diseases in the Finnish population, highlighting the importance of international cooperation in developing human disease modeling strategies. This approach also promotes a broader understanding of molecular pathways in both rare and common diseases.
The modification of genes in animal models has evidently and comprehensively improved our knowledge on proteins and signaling pathways in human physiology and pathology. In this review, we discuss almost 40 monogenic rare diseases that are enriched in the Finnish population and defined as the Finnish disease heritage (FDH). We will highlight how gene-modified mouse models have greatly facilitated the understanding of the pathological manifestations of these diseases and how some of the diseases still lack proper models. We urge the establishment of subsequent international consortiums to cooperatively plan and carry out future human disease modeling strategies. Detailed information on disease mechanisms brings along broader understanding of the molecular pathways they act along both parallel and transverse to the proteins affected in rare diseases, therefore also aiding understanding of common disease pathologies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available